APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Piroxicam Oral Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Piroxicam Oral Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174026070327 December 2025180 pages

Choose your research edition.

Industry ResearchPiroxicam Oral Tablets Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Piroxicam Oral Tablets Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Piroxicam Oral Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Piroxicam Oral Tablets Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Piroxicam Oral Tablets Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Piroxicam Oral Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Piroxicam Oral Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Piroxicam Oral Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Piroxicam Oral Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Piroxicam Oral Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Piroxicam Oral Tablets include Yunpeng Pharmaceutical Group, Shandong Fangming Pharmaceutical Group, Wanrong Pharmaceutical (Langzhi Group), Nantong Jinghua Pharmaceutical, Wellona Pharma, SK Chemical, Pfizer, Chr. Olesen Group and Adva Care Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Piroxicam Oral Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Piroxicam Oral Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Piroxicam Oral Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Piroxicam Oral Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Piroxicam Oral Tablets Segment by Company

Yunpeng Pharmaceutical Group

Shandong Fangming Pharmaceutical Group

Wanrong Pharmaceutical (Langzhi Group)

Nantong Jinghua Pharmaceutical

Wellona Pharma

SK Chemical

Pfizer

Chr. Olesen Group

Adva Care Pharma

Piroxicam Oral Tablets Segment by Type

Regular Release Tablets

Modified Release Tablets

Piroxicam Oral Tablets Segment by Application

Hospital

Clinic

Pharmacy

Piroxicam Oral Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Piroxicam Oral Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Piroxicam Oral Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Piroxicam Oral Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Piroxicam Oral Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Piroxicam Oral Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Piroxicam Oral Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Piroxicam Oral Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Piroxicam Oral Tablets Industry Trends Table 2. Piroxicam Oral Tablets Industry Drivers Table 3. Piroxicam Oral Tablets Industry Opportunities and Challenges Table 4. Piroxicam Oral Tablets Industry Restraints Table 5. Global Piroxicam Oral Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Piroxicam Oral Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Piroxicam Oral Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Piroxicam Oral Tablets Sales Market Share by Manufacturers Table 9. Global Piroxicam Oral Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Piroxicam Oral Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Piroxicam Oral Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Piroxicam Oral Tablets Manufacturers, Product Type & Application Table 13. Global Piroxicam Oral Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Piroxicam Oral Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Regular Release Tablets Table 17. Major Manufacturers of Modified Release Tablets Table 18. Global Piroxicam Oral Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Piroxicam Oral Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Piroxicam Oral Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Piroxicam Oral Tablets Sales Market Share by Type (2021-2026) Table 22. Global Piroxicam Oral Tablets Sales Market Share by Type (2027-2032) Table 23. Global Piroxicam Oral Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Piroxicam Oral Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Piroxicam Oral Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Piroxicam Oral Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Piroxicam Oral Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Pharmacy Table 31. Global Piroxicam Oral Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Piroxicam Oral Tablets Sales by Application (2021-2026) & (K Units) Table 33. Global Piroxicam Oral Tablets Sales by Application (2027-2032) & (K Units) Table 34. Global Piroxicam Oral Tablets Sales Market Share by Application (2021-2026) Table 35. Global Piroxicam Oral Tablets Sales Market Share by Application (2027-2032) Table 36. Global Piroxicam Oral Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Piroxicam Oral Tablets Revenue by Application (2021-2026) & (K Units) Table 38. Global Piroxicam Oral Tablets Revenue by Application (2027-2032) & (K Units) Table 39. Global Piroxicam Oral Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Piroxicam Oral Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Piroxicam Oral Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Piroxicam Oral Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Piroxicam Oral Tablets Sales Market Share by Region (2021-2026) Table 44. Global Piroxicam Oral Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Piroxicam Oral Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Piroxicam Oral Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Piroxicam Oral Tablets Sales by Country (2021-2026) & (K Units) Table 48. North America Piroxicam Oral Tablets Sales by Country (2027-2032) & (K Units) Table 49. Europe Piroxicam Oral Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Piroxicam Oral Tablets Sales by Country (2021-2026) & (K Units) Table 51. Europe Piroxicam Oral Tablets Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Piroxicam Oral Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Piroxicam Oral Tablets Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Piroxicam Oral Tablets Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Piroxicam Oral Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Piroxicam Oral Tablets Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Piroxicam Oral Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Piroxicam Oral Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Piroxicam Oral Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Piroxicam Oral Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Piroxicam Oral Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Piroxicam Oral Tablets Revenue Market Share by Region (2027-2032) Table 63. Yunpeng Pharmaceutical Group Company Information Table 64. Yunpeng Pharmaceutical Group Business Overview Table 65. Yunpeng Pharmaceutical Group Piroxicam Oral Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Yunpeng Pharmaceutical Group Piroxicam Oral Tablets Product Portfolio Table 67. Yunpeng Pharmaceutical Group Recent Development Table 68. Shandong Fangming Pharmaceutical Group Company Information Table 69. Shandong Fangming Pharmaceutical Group Business Overview Table 70. Shandong Fangming Pharmaceutical Group Piroxicam Oral Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Shandong Fangming Pharmaceutical Group Piroxicam Oral Tablets Product Portfolio Table 72. Shandong Fangming Pharmaceutical Group Recent Development Table 73. Wanrong Pharmaceutical (Langzhi Group) Company Information Table 74. Wanrong Pharmaceutical (Langzhi Group) Business Overview Table 75. Wanrong Pharmaceutical (Langzhi Group) Piroxicam Oral Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Wanrong Pharmaceutical (Langzhi Group) Piroxicam Oral Tablets Product Portfolio Table 77. Wanrong Pharmaceutical (Langzhi Group) Recent Development Table 78. Nantong Jinghua Pharmaceutical Company Information Table 79. Nantong Jinghua Pharmaceutical Business Overview Table 80. Nantong Jinghua Pharmaceutical Piroxicam Oral Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Nantong Jinghua Pharmaceutical Piroxicam Oral Tablets Product Portfolio Table 82. Nantong Jinghua Pharmaceutical Recent Development Table 83. Wellona Pharma Company Information Table 84. Wellona Pharma Business Overview Table 85. Wellona Pharma Piroxicam Oral Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Wellona Pharma Piroxicam Oral Tablets Product Portfolio Table 87. Wellona Pharma Recent Development Table 88. SK Chemical Company Information Table 89. SK Chemical Business Overview Table 90. SK Chemical Piroxicam Oral Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. SK Chemical Piroxicam Oral Tablets Product Portfolio Table 92. SK Chemical Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Piroxicam Oral Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Pfizer Piroxicam Oral Tablets Product Portfolio Table 97. Pfizer Recent Development Table 98. Chr. Olesen Group Company Information Table 99. Chr. Olesen Group Business Overview Table 100. Chr. Olesen Group Piroxicam Oral Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Chr. Olesen Group Piroxicam Oral Tablets Product Portfolio Table 102. Chr. Olesen Group Recent Development Table 103. Adva Care Pharma Company Information Table 104. Adva Care Pharma Business Overview Table 105. Adva Care Pharma Piroxicam Oral Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Adva Care Pharma Piroxicam Oral Tablets Product Portfolio Table 107. Adva Care Pharma Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Piroxicam Oral Tablets Distributors List Table 111. Piroxicam Oral Tablets Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Piroxicam Oral Tablets Product Image Figure 2. Global Piroxicam Oral Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Piroxicam Oral Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Piroxicam Oral Tablets Sales (2021-2032) & (K Units) Figure 5. Global Piroxicam Oral Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Piroxicam Oral Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Regular Release Tablets Image Figure 9. Modified Release Tablets Image Figure 10. Global Piroxicam Oral Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Piroxicam Oral Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Piroxicam Oral Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Piroxicam Oral Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Piroxicam Oral Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Piroxicam Oral Tablets Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Pharmacy Image Figure 19. Global Piroxicam Oral Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Piroxicam Oral Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Piroxicam Oral Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Piroxicam Oral Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Piroxicam Oral Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Piroxicam Oral Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Piroxicam Oral Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Piroxicam Oral Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Piroxicam Oral Tablets Sales Market Share by Country (2021-2032) Figure 39. China Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Piroxicam Oral Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Piroxicam Oral Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Piroxicam Oral Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Piroxicam Oral Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Piroxicam Oral Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Piroxicam Oral Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Piroxicam Oral Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Piroxicam Oral Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Piroxicam Oral Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Piroxicam Oral Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Piroxicam Oral Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Piroxicam Oral Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Piroxicam Oral Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Piroxicam Oral Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Regular Release Tablets
  • Modified Release Tablets
Applications
  • Hospital
  • Clinic
  • Pharmacy
Companies covered
  • Yunpeng Pharmaceutical Group
  • Shandong Fangming Pharmaceutical Group
  • Wanrong Pharmaceutical (Langzhi Group)
  • Nantong Jinghua Pharmaceutical
  • Wellona Pharma
  • SK Chemical
  • Pfizer
  • Chr. Olesen Group
  • Adva Care Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Piroxicam Oral Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Piroxicam Oral Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Piroxicam Oral Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Piroxicam Oral Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Piroxicam Oral Tablets Market Dynamics
  1. 2.1 Piroxicam Oral Tablets Industry Trends
  2. 2.2 Piroxicam Oral Tablets Industry Drivers
  3. 2.3 Piroxicam Oral Tablets Industry Opportunities and Challenges
  4. 2.4 Piroxicam Oral Tablets Industry Restraints
3 Piroxicam Oral Tablets Market by Manufacturers
  1. 3.1 Global Piroxicam Oral Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Piroxicam Oral Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Piroxicam Oral Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Piroxicam Oral Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Piroxicam Oral Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Piroxicam Oral Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Piroxicam Oral Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Piroxicam Oral Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Piroxicam Oral Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Piroxicam Oral Tablets Tier 1, Tier 2, and Tier 3
4 Piroxicam Oral Tablets Market by Type
  1. 4.1 Piroxicam Oral Tablets Type Introduction
  2. 4.1.1 Regular Release Tablets
  3. 4.1.2 Modified Release Tablets
  4. 4.2 Global Piroxicam Oral Tablets Sales by Type
  5. 4.2.1 Global Piroxicam Oral Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Piroxicam Oral Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Piroxicam Oral Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Piroxicam Oral Tablets Revenue by Type
  9. 4.3.1 Global Piroxicam Oral Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Piroxicam Oral Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Piroxicam Oral Tablets Revenue Market Share by Type (2021-2032)
5 Piroxicam Oral Tablets Market by Application
  1. 5.1 Piroxicam Oral Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Pharmacy
  5. 5.2 Global Piroxicam Oral Tablets Sales by Application
  6. 5.2.1 Global Piroxicam Oral Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Piroxicam Oral Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Piroxicam Oral Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Piroxicam Oral Tablets Revenue by Application
  10. 5.3.1 Global Piroxicam Oral Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Piroxicam Oral Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Piroxicam Oral Tablets Revenue Market Share by Application (2021-2032)
6 Global Piroxicam Oral Tablets Sales by Region
  1. 6.1 Global Piroxicam Oral Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Piroxicam Oral Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Piroxicam Oral Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Piroxicam Oral Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Piroxicam Oral Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Piroxicam Oral Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Piroxicam Oral Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Piroxicam Oral Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Piroxicam Oral Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Piroxicam Oral Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Piroxicam Oral Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Piroxicam Oral Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Piroxicam Oral Tablets Revenue by Region
  1. 7.1 Global Piroxicam Oral Tablets Revenue by Region
  2. 7.1.1 Global Piroxicam Oral Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Piroxicam Oral Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Piroxicam Oral Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Piroxicam Oral Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Piroxicam Oral Tablets Revenue (2021-2032)
  8. 7.2.2 North America Piroxicam Oral Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Piroxicam Oral Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Piroxicam Oral Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Piroxicam Oral Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Piroxicam Oral Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Piroxicam Oral Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Piroxicam Oral Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yunpeng Pharmaceutical Group
  2. 8.1.1 Yunpeng Pharmaceutical Group Company Information
  3. 8.1.2 Yunpeng Pharmaceutical Group Business Overview
  4. 8.1.3 Yunpeng Pharmaceutical Group Piroxicam Oral Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yunpeng Pharmaceutical Group Piroxicam Oral Tablets Product Portfolio
  6. 8.1.5 Yunpeng Pharmaceutical Group Recent Developments
  7. 8.2 Shandong Fangming Pharmaceutical Group
  8. 8.2.1 Shandong Fangming Pharmaceutical Group Company Information
  9. 8.2.2 Shandong Fangming Pharmaceutical Group Business Overview
  10. 8.2.3 Shandong Fangming Pharmaceutical Group Piroxicam Oral Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shandong Fangming Pharmaceutical Group Piroxicam Oral Tablets Product Portfolio
  12. 8.2.5 Shandong Fangming Pharmaceutical Group Recent Developments
  13. 8.3 Wanrong Pharmaceutical (Langzhi Group)
  14. 8.3.1 Wanrong Pharmaceutical (Langzhi Group) Company Information
  15. 8.3.2 Wanrong Pharmaceutical (Langzhi Group) Business Overview
  16. 8.3.3 Wanrong Pharmaceutical (Langzhi Group) Piroxicam Oral Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Wanrong Pharmaceutical (Langzhi Group) Piroxicam Oral Tablets Product Portfolio
  18. 8.3.5 Wanrong Pharmaceutical (Langzhi Group) Recent Developments
  19. 8.4 Nantong Jinghua Pharmaceutical
  20. 8.4.1 Nantong Jinghua Pharmaceutical Company Information
  21. 8.4.2 Nantong Jinghua Pharmaceutical Business Overview
  22. 8.4.3 Nantong Jinghua Pharmaceutical Piroxicam Oral Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Nantong Jinghua Pharmaceutical Piroxicam Oral Tablets Product Portfolio
  24. 8.4.5 Nantong Jinghua Pharmaceutical Recent Developments
  25. 8.5 Wellona Pharma
  26. 8.5.1 Wellona Pharma Company Information
  27. 8.5.2 Wellona Pharma Business Overview
  28. 8.5.3 Wellona Pharma Piroxicam Oral Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Wellona Pharma Piroxicam Oral Tablets Product Portfolio
  30. 8.5.5 Wellona Pharma Recent Developments
  31. 8.6 SK Chemical
  32. 8.6.1 SK Chemical Company Information
  33. 8.6.2 SK Chemical Business Overview
  34. 8.6.3 SK Chemical Piroxicam Oral Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 SK Chemical Piroxicam Oral Tablets Product Portfolio
  36. 8.6.5 SK Chemical Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Piroxicam Oral Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Piroxicam Oral Tablets Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Chr. Olesen Group
  44. 8.8.1 Chr. Olesen Group Company Information
  45. 8.8.2 Chr. Olesen Group Business Overview
  46. 8.8.3 Chr. Olesen Group Piroxicam Oral Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Chr. Olesen Group Piroxicam Oral Tablets Product Portfolio
  48. 8.8.5 Chr. Olesen Group Recent Developments
  49. 8.9 Adva Care Pharma
  50. 8.9.1 Adva Care Pharma Company Information
  51. 8.9.2 Adva Care Pharma Business Overview
  52. 8.9.3 Adva Care Pharma Piroxicam Oral Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Adva Care Pharma Piroxicam Oral Tablets Product Portfolio
  54. 8.9.5 Adva Care Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Piroxicam Oral Tablets Value Chain Analysis
  2. 9.1.1 Piroxicam Oral Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Piroxicam Oral Tablets Production Mode & Process
  6. 9.2 Piroxicam Oral Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Piroxicam Oral Tablets Distributors
  9. 9.2.3 Piroxicam Oral Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst